论文部分内容阅读
目的:观察匹多莫德颗粒治疗手足口病肺炎的疗效方法:收集2009年5月-2011年6月开平市中心医院儿科住院的手足口病并发支气管肺炎的患儿68例,随机分为治疗组和对照组,每组34例,两组患儿皆行常规综合治疗,治疗组在常规综合治疗基础上加服匹多莫德颗粒,比较两组疗效。结果:治疗1周后,两组疗效比较,对照组总有效率73.53%,治疗组94.12%,P<0.05。结论:口服匹多莫德颗粒辅助治疗手足口病肺炎,能够提高治愈率,缩短治疗时间,辅助效果显著,值得临床推广应用。
Objective: To observe the effect of Pidotimod on the treatment of hand, foot and mouth disease pneumonia in children. Methods: From May 2009 to June 2011, 68 children with hand-foot-mouth disease and bronchial pneumonia who were hospitalized in pediatric department of Kaiping Central Hospital were randomly divided into treatment group Group and control group, 34 cases in each group. Children in both groups underwent routine comprehensive treatment. The treatment group was given Pidotimod granules on the basis of conventional comprehensive treatment, and the curative effect was compared between the two groups. Results: After one week of treatment, the total effective rate was 73.53% in the control group and 94.12% in the treatment group, P <0.05. Conclusion: Pidotimod is an effective adjuvant therapy for hand-foot-mouth disease pneumonia, which can improve the cure rate and shorten the treatment time. The adjuvant effect is significant and worthy of clinical application.